References
- Xu L, Bian X, Yang J, et al. Safety and effectiveness of laparoscopic renal biopsy: a single-center review and meta-analysis. Ren Fail. 2024;46(1):2312536.
- Yoon SY, Kim JS, Jeong KH, et al. Acute kidney injury: biomarker-guided diagnosis and management. Medicina. 2022;58(3):340. doi: 10.3390/medicina58030340.
- Doherty M. Value of interventional radiology: past, present, and future. Semin Intervent Radiol. 2019;36(1):26–28. doi: 10.1055/s-0039-1679951.
- Brachemi S, Bollée G. Renal biopsy practice: what is the gold standard? World J Nephrol. 2014;3(4):287–294. doi: 10.5527/wjn.v3.i4.287.
- Al Turk AA, Estiverne C, Agrawal PR, et al. Trends and outcomes of the use of percutaneous native kidney biopsy in the United States: 5-year data analysis of the nationwide inpatient sample. Clin Kidney J. 2018;11(3):330–336. doi: 10.1093/ckj/sfx102.
- Bolufer M, García-Carro C, Agraz I, et al. Biopsia renal transyugular. La alternativa a la biopsia percutánea en pacientes de alto riesgo. Nefrologia (Engl Ed). 2020;40(6):634–639.
- St. Jeor JD, Reisenauer CJ, Andrews JC, et al. Transjugular renal biopsy bleeding risk and diagnostic yield: a systematic review. J Vasc Interv Radiol. 2020;31(12):2106–2112. doi: 10.1016/j.jvir.2020.07.016.
- Vilalta A. Cost and utilization trends of percutaneous kidney biopsy in kidney transplant patients: a 4-year claims data analysis [Internet]. Transplantation. 2023 Oct [cited 2024 Mar 17]. Available from: http://medrxiv.org/lookup/doi/10<?sch-permit JATS-0034-007?>.1101/2023.10.13.23295504